Chirality in Drug Design and Synthesis

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Chirality in Drug Design and Synthesis by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781483288246
Publisher: Elsevier Science Publication: October 22, 2013
Imprint: Academic Press Language: English
Author:
ISBN: 9781483288246
Publisher: Elsevier Science
Publication: October 22, 2013
Imprint: Academic Press
Language: English

Chirality in Drug Design and Synthesis is a collection of papers that discusses the property of asymmetry in the structural and synthetic chemistry of natural products, including the significance of chirality in medicinal chemistry. These papers examine the need for the preparation and study of pure enantiomers of chiral drug substances and their mechanism of interaction with enzymes and receptors. These papers also investigate the techniques in studying these interactions, as well as analyze the methods for their synthesis in enantiomerically pure form. One paper discusses the pharmacological and pharmacokinetic analyses made that point to the differences in the activity and disposition of enantiometric pairs. Another paper reviews the implications of the neglect of stereoselectivity at the different levels during the examination process of racemic drugs. Since no general guidelines exists for the development of drugs with chiral centers, one paper suggests a case-by-case approach in evaluating the safety and efficacy of drugs, particularly as regards how isomers differ in their effects. This collection is suitable for the pharmacologist, medicinal chemists, toxicologists, mechanistic chemists and synthetic organic chemists.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Chirality in Drug Design and Synthesis is a collection of papers that discusses the property of asymmetry in the structural and synthetic chemistry of natural products, including the significance of chirality in medicinal chemistry. These papers examine the need for the preparation and study of pure enantiomers of chiral drug substances and their mechanism of interaction with enzymes and receptors. These papers also investigate the techniques in studying these interactions, as well as analyze the methods for their synthesis in enantiomerically pure form. One paper discusses the pharmacological and pharmacokinetic analyses made that point to the differences in the activity and disposition of enantiometric pairs. Another paper reviews the implications of the neglect of stereoselectivity at the different levels during the examination process of racemic drugs. Since no general guidelines exists for the development of drugs with chiral centers, one paper suggests a case-by-case approach in evaluating the safety and efficacy of drugs, particularly as regards how isomers differ in their effects. This collection is suitable for the pharmacologist, medicinal chemists, toxicologists, mechanistic chemists and synthetic organic chemists.

More books from Elsevier Science

Cover of the book Experimental Characterization, Predictive Mechanical and Thermal Modeling of Nanostructures and Their Polymer Composites by
Cover of the book Advances in Structure and Activity Relationship of Coumarin Derivatives by
Cover of the book User Experience Management by
Cover of the book Hazard Mitigation in Emergency Management by
Cover of the book Workplace Security Essentials by
Cover of the book The Classical Theory of Fields by
Cover of the book Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging by
Cover of the book Taking the LEAP by
Cover of the book Biotechnology of Metals by
Cover of the book Developments in Palygorskite-Sepiolite Research by
Cover of the book Rethinking Valuation and Pricing Models by
Cover of the book Nonlinear Fiber Optics by
Cover of the book The Psychology and Sociology of Wrongful Convictions by
Cover of the book Environmental Ecology by
Cover of the book International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy